Mainolfi Nello: insider trades.
Mainolfi Nello reported 8 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 6 sales ($15.2M), across 1 company.
- Transactions
- 8
- Purchases (P)
- 0
- Sales (S)
- 6
- Companies
- 1
- Name as filed
- Mainolfi Nello
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Kymera Therapeutics, Inc. (KYMR) | Director, Officer · Chief Executive Officer | 8 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-07-07 | Kymera Therapeutics, Inc. | M | 50,000 | $2.08 | 716,568 | Form 4 |
| 2026-07-07 | Kymera Therapeutics, Inc. | S | 50,000 | $119 | 666,568 | Form 4 |
| 2026-07-01 | Kymera Therapeutics, Inc. | M | 80,000 | $2.08 | 746,568 | Form 4 |
| 2026-07-01 | Kymera Therapeutics, Inc. | S | 1,883 | $112.8 | 744,685 | Form 4 |
| 2026-07-01 | Kymera Therapeutics, Inc. | S | 6,626 | $113.98 | 738,059 | Form 4 |
| 2026-07-01 | Kymera Therapeutics, Inc. | S | 44,050 | $115.69 | 669,904 | Form 4 |
| 2026-07-01 | Kymera Therapeutics, Inc. | S | 24,105 | $114.96 | 713,954 | Form 4 |
| 2026-07-01 | Kymera Therapeutics, Inc. | S | 3,336 | $116.56 | 666,568 | Form 4 |
Questions
What stock did Mainolfi Nello buy or sell?
Mainolfi Nello reported 8 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 6 sales ($15.2M), across 1 company.
Is Mainolfi Nello the same person as other filers with this name?
This page covers SEC CIK 1821189 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/mainolfi-nello-1821189.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.